Plain-English translation of NCT07154758 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial uses a Swedish heart failure registry to identify patients with reduced heart function who may benefit from better medication management, device therapy, or other treatments. The study compares two groups: patients screened through the registry who receive treatment optimization support, and patients receiving usual care. The goal is to see whether systematic screening helps more patients get the medicines and therapies they need.
Many patients with heart failure don't receive all the medications and treatments that could help them live longer and feel better, even though these therapies are proven to work. This trial aims to see whether using a registry to identify and support patients can close that gap and improve outcomes.
You likely qualify if…
You likely don't qualify if…
If you are selected for the screening group, your medical records will be reviewed to see if you would benefit from medication changes, testing for iron deficiency, device therapy, or heart rehabilitation. Your doctor will then be notified and support will be offered to help you get the appropriate treatment. If you are in the usual care group, you will continue receiving standard treatment without the registry screening intervention. The study will track which patients receive new or adjusted medications, are referred for devices, or get other treatments over time.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Sweden